Legal Jobs Blog

08-2673 Litigation Paralegal US-PA-Horsham
08-2671 Litigation Attorney US-PA-Horsham

U.S. Fed. Circuit Court of Appeals, March 07, 2008
Pfizer, Inc. v. Teva Pharms. USA, Inc., No. 2007-1271
In a patent case involving the active ingredient in the drug Celebrex, a judgment finding that defendant infringed three patents owned by Pfizer and upholding their validity and enforceability is affirmed in part and reversed in part where: 1) the asserted claims of one patent were invalid based on double patenting; 2) certain claims of two patents were not invalid for a best mode violation; and 3) the patents were not unenforceable for inequitable conduct.